Quick Takeaways
- This page summarizes Roger E. Susi's Form 4 filing for IRADIMED CORP (IRMD).
- 2 reported transactions and 0 derivative rows are listed below.
- Filing timestamp: 01 Nov 2023, 16:15.
Roger E. Susi - 30 Oct 2023 Form 4 Insider Report for IRADIMED CORP (IRMD)
- Signature
- /s/ Roger E. Susi
- Issuer symbol
- IRMD
- Transactions as of
- 30 Oct 2023
- Net transactions value
- -$401,604
- Form type
- 4
- Filing time
- 01 Nov 2023, 16:15:09 UTC
- Previous filing
- 27 Oct 2023
- Next filing
- 09 Nov 2023
- SEC
- View on sec.gov
Quoteable Key Fact
"Roger E. Susi filed Form 4 for IRADIMED CORP (IRMD) on 01 Nov 2023."
What Changed
- Previous filing in this sequence was filed on 27 Oct 2023.
- Current net transaction value: -$401,604.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
IRMD
transaction
Common Stock
Sale
- Transaction value
- $199,588
- Shares
- -5,000
- Change %
- -2%
- Price
- $39.92
- Shares after
- 247,950
- Date
- 30 Oct 2023
- Ownership
- By Roger E. Susi Revocable Trust
- Footnotes
- F1, F2
IRMD
transaction
Common Stock
Sale
- Transaction value
- $202,016
- Shares
- -5,000
- Change %
- -2%
- Price
- $40.40
- Shares after
- 242,950
- Date
- 31 Oct 2023
- Ownership
- By Roger E. Susi Revocable Trust
- Footnotes
- F1, F3
IRMD
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,362,500
- Date
- 30 Oct 2023
- Ownership
- By Matthew Susi 2008 Dynasty Trust
- Footnotes
- F4
IRMD
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,362,500
- Date
- 30 Oct 2023
- Ownership
- By Phillip Susi 2008 Dynasty Trust
- Footnotes
- F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 13, 2023. |
| F2 | This transaction was executed in multiple trades at prices ranging from $38.99 to $40.37. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F3 | This transaction was executed in multiple trades at prices ranging from $39.81 to $40.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F4 | The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose. |